besthealtharticle.com
Home »
Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment. Patients experiencing a heart attack—known as a myocardial infarction or an acute coronary syndrome—have sharply diminished blood flow in coronary arteries, with a high risk of heart […]
Rush University Medical Center is the first health care organization to launch medical record company Epic’s module for genomic results, giving providers the tools they need to tailor patient care at the molecular level. Rush will use the module as part of its Precision Oncology Center to integrate the power of genomic sequencing data into […]
Researchers from the Faculty of Medicine and the Institute for Molecular Medicine (FIMM) at the University of Helsinki have developed a computational model, Combined Essentiality Scoring (CES) that enables accurate identification of essential genes in cancer cells for development of anti-cancer drugs. Why are the essential genes important in cancer? Cancer is the leading cause […]
Hope for thousands of prostate cancer sufferers as trial finds a ‘precision’ drug can help incurable patients live almost four months longer Lynparza extended survival of men with advanced prostate cancer by 7.4 months That is more than double the NHS hormonal treatments (3.5 months) Lynparza works by targeting faulty DNA which helps cancer cells […]
A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives—signaling a new era of precision medicine for young patients. The pilot including more than 200 children found that half had gene mutations that are targetable by adult cancer drugs […]
More than 174,000 men will be diagnosed with prostate cancer this year, according to the American Cancer Society, putting it behind only skin cancer as the most common cancer among American men. Ji-Xin Cheng, adjunct professor of Purdue’s Weldon School of Biomedical Engineering and the Department of Chemistry, says a paper in the New England […]
A study led by researchers from the Texas A&M University System and Central Texas Veterans Health Care System, or CTVHCS, shows how a protein known as STING could be a therapeutic target for non-alcoholic fatty liver disease, or NAFLD. The study, “Expression of STING Is Increased in Liver Tissues from Patients with NAFLD and Promotes […]